Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares Issued
Ratios

Bioventus (BVS) Long-Term Debt Issuances (2020 - 2025)

Bioventus' Long-Term Debt Issuances history spans 5 years, with the latest figure at $15.0 million for Q3 2025.

  • For Q3 2025, Long-Term Debt Issuances changed N/A year-over-year to $15.0 million; the TTM value through Dec 2025 reached $45.0 million, changed N/A, while the annual FY2025 figure was $31.9 million, N/A changed from the prior year.
  • Long-Term Debt Issuances reached $15.0 million in Q3 2025 per BVS's latest filing, roughly flat from $15.0 million in the prior quarter.
  • In the past five years, Long-Term Debt Issuances ranged from a high of $257.5 million in Q4 2021 to a low of -$64.0 million in Q4 2023.
  • Average Long-Term Debt Issuances over 4 years is $38.2 million, with a median of $15.0 million recorded in 2022.
  • The largest YoY upside for Long-Term Debt Issuances was 226.67% in 2023 against a maximum downside of 72.56% in 2023.
  • A 4-year view of Long-Term Debt Issuances shows it stood at $257.5 million in 2021, then crashed by 78.77% to $54.7 million in 2022, then tumbled by 217.09% to -$64.0 million in 2023, then surged by 123.44% to $15.0 million in 2025.
  • Per Business Quant, the three most recent readings for BVS's Long-Term Debt Issuances are $15.0 million (Q3 2025), $15.0 million (Q2 2025), and $15.0 million (Q1 2025).